US FDA Approves First Oral Cholesterol Pill to Replace Injections
The US Food and Drug Administration has approved Lipfendra, making it the world’s first oral PCSK9 inhibitor tablet designed to dramatically lower bad cholesterol for adults with high cholesterol conditions, including heterozygous familial hypercholesterolaemia, according to recent regulatory announcements. This milestone offers a daily pill alternative to injectable therapies, though the drug is not yet … Read more
